دورة المؤشرنت للتحليل الفني
50 دينار كويتي
سهم Bany سينفجر اليوم
- بادئ الموضوع ayoop
- تاريخ البدء
best
عضو نشط
- التسجيل
- 13 نوفمبر 2006
- المشاركات
- 1,857
ارتفاع بعد هذا الخبر اليوم الساعة 11.45 صباحا عندهم
Banyan Corporation Reports Strong Sales For Its Virtual Medical Systems, Inc. Subsidiary
Banyan Corporation's (OTCBB:BANY) subsidiary, Virtual Medical Systems, Inc. ("VMS"), announces it has now sold 66 of its new VT3000 Nerve Conduction Velocity (NCV) testing devices since November 2006. The VT3000 is a state of the art NCV device offering live viewing and supervision of testing by board certified physicians. These 66 machines are expected to add $1.58 million in revenue to VMS. The company, in an earlier release, reported that management projected 2007 sales of 144 machines corresponding to $3.4 million in revenue. Now, as a result of these increased sales, management has revised its estimates upward to 166 machines and $3.98 million in revenue.
Banyan CEO Michael Gelmon stated, "This is exciting news, but not unexpected. The diagnostic industry has long been waiting for the development of a machine with the properties of the VT3000. In December, 36% of the patients tested in our diagnostic testing subsidiary were being tested utilizing proprietary technology incorporated in the VT3000. We believe our technology should be the gold standard in the industry shortly. In addition, it represents significant growth and long term viability of the VMS model."
For more information on Chiropractic USA, Diagnostic USA, and Premier Medical Group contact Banyan Corporation, Investor Relations, toll-free at (800) 808-0899 or visit www.chiropracticUSA.net.
About Banyan Corporation
Banyan Corporation is a publicly traded holding company focused on investing in and building a network of operating subsidiaries engaged in various innovative businesses. Currently the company's subsidiary, Chiropractic USA, Inc. is focusing on the development of branded chiropractic clinics throughout North America by way of franchising chiropractic clinics under its marks and uniform operating systems and practices. The company's other subsidiaries; Premier Medical Group LLC, and Diagnostic USA, Inc. provide diagnostic testing to physicians nationwide.
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made or to be made by Banyan Corporation) contains statements that are forward-looking, such as statements relating to the future anticipated direction of the high technology industry, plans for future expansion, various business development activities, planned capital expenditures, future funding sources, anticipated sales growth and potential contracts. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ from those expressed in any forward-looking statements made by or on behalf of Banyan Corporation. These risks and uncertainties include, but are not limited to, those relating to development and expansion activities, dependence on existing management, financing activities, domestic and global economic conditions, changes in federal or state tax laws, and market competition factors. For a description of additional risks and uncertainties, please refer to Banyan's filings with the Securities and Exchange Commission.
Banyan Corporation, Los Angeles
Michael Gelmon, CEO, 800-808-0899
adavis@chiropracticusa.net
http://www.ChiropracticUSA.net
Source: Business Wire (January 11, 2007 - 11:15 AM EST)
News by QuoteMedia
Banyan Corporation Reports Strong Sales For Its Virtual Medical Systems, Inc. Subsidiary
Banyan Corporation's (OTCBB:BANY) subsidiary, Virtual Medical Systems, Inc. ("VMS"), announces it has now sold 66 of its new VT3000 Nerve Conduction Velocity (NCV) testing devices since November 2006. The VT3000 is a state of the art NCV device offering live viewing and supervision of testing by board certified physicians. These 66 machines are expected to add $1.58 million in revenue to VMS. The company, in an earlier release, reported that management projected 2007 sales of 144 machines corresponding to $3.4 million in revenue. Now, as a result of these increased sales, management has revised its estimates upward to 166 machines and $3.98 million in revenue.
Banyan CEO Michael Gelmon stated, "This is exciting news, but not unexpected. The diagnostic industry has long been waiting for the development of a machine with the properties of the VT3000. In December, 36% of the patients tested in our diagnostic testing subsidiary were being tested utilizing proprietary technology incorporated in the VT3000. We believe our technology should be the gold standard in the industry shortly. In addition, it represents significant growth and long term viability of the VMS model."
For more information on Chiropractic USA, Diagnostic USA, and Premier Medical Group contact Banyan Corporation, Investor Relations, toll-free at (800) 808-0899 or visit www.chiropracticUSA.net.
About Banyan Corporation
Banyan Corporation is a publicly traded holding company focused on investing in and building a network of operating subsidiaries engaged in various innovative businesses. Currently the company's subsidiary, Chiropractic USA, Inc. is focusing on the development of branded chiropractic clinics throughout North America by way of franchising chiropractic clinics under its marks and uniform operating systems and practices. The company's other subsidiaries; Premier Medical Group LLC, and Diagnostic USA, Inc. provide diagnostic testing to physicians nationwide.
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made or to be made by Banyan Corporation) contains statements that are forward-looking, such as statements relating to the future anticipated direction of the high technology industry, plans for future expansion, various business development activities, planned capital expenditures, future funding sources, anticipated sales growth and potential contracts. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ from those expressed in any forward-looking statements made by or on behalf of Banyan Corporation. These risks and uncertainties include, but are not limited to, those relating to development and expansion activities, dependence on existing management, financing activities, domestic and global economic conditions, changes in federal or state tax laws, and market competition factors. For a description of additional risks and uncertainties, please refer to Banyan's filings with the Securities and Exchange Commission.
Banyan Corporation, Los Angeles
Michael Gelmon, CEO, 800-808-0899
adavis@chiropracticusa.net
http://www.ChiropracticUSA.net
Source: Business Wire (January 11, 2007 - 11:15 AM EST)
News by QuoteMedia
al7bebe
عضو نشط
- التسجيل
- 24 مارس 2005
- المشاركات
- 10,052
الدبل قبل نهايه الاسبوع
شراء حامي وتداول قوي.
http://messages.finance.yahoo.com/Stocks_(A_to_Z)/Stocks_B/messagesview?bn=38990
شراء حامي وتداول قوي.
http://messages.finance.yahoo.com/Stocks_(A_to_Z)/Stocks_B/messagesview?bn=38990
al7bebe
عضو نشط
- التسجيل
- 24 مارس 2005
- المشاركات
- 10,052
شراء ثلاثه مليون سهم استثماري والبيع مع الاخبار القادمه.
Q4 تقرير الارباح قريب جدا واخبار قادمه تبشر بنتائج دخل ماليه ممتاز.
على العموم السهم توقيت شراء بالنسبه لي ممتاز. على سعر 0.0026
--------
I guess Q4 numbers should be released in the second week of Feb.
-----------------------------------------------------
VT3000 sales
Jan 11 news stated 66 units were sold since Nov 2006. They revised 2007 sales to up to 166 from 144 as a result. This means 26 of the 66 units were sold in January 2007 and 40 were sold in 2006. At an estimated unit price of $24 K, the 2006 sales will add $960K to Q4 sales numbers.
Considering Q3 total revenue before VT3000 launch was $1.4M with a net income of (576) these sales should push Banyan to profitability in Q4 IMO. This is without taking into consideration other increases in revenue..
I guess Q4 numbers should be released in the second week of Feb
---------------
بالتوفيق للجميع وبالذات اخي الشعثاني واقوله الحمدالله على السلامه.
Q4 تقرير الارباح قريب جدا واخبار قادمه تبشر بنتائج دخل ماليه ممتاز.
على العموم السهم توقيت شراء بالنسبه لي ممتاز. على سعر 0.0026
--------
I guess Q4 numbers should be released in the second week of Feb.
-----------------------------------------------------
VT3000 sales
Jan 11 news stated 66 units were sold since Nov 2006. They revised 2007 sales to up to 166 from 144 as a result. This means 26 of the 66 units were sold in January 2007 and 40 were sold in 2006. At an estimated unit price of $24 K, the 2006 sales will add $960K to Q4 sales numbers.
Considering Q3 total revenue before VT3000 launch was $1.4M with a net income of (576) these sales should push Banyan to profitability in Q4 IMO. This is without taking into consideration other increases in revenue..
I guess Q4 numbers should be released in the second week of Feb
---------------
بالتوفيق للجميع وبالذات اخي الشعثاني واقوله الحمدالله على السلامه.
لافي العتيبي
عضو نشط
- التسجيل
- 21 أغسطس 2006
- المشاركات
- 563
يعني مراح يكسر 30 اليوم
al7bebe
عضو نشط
- التسجيل
- 24 مارس 2005
- المشاركات
- 10,052
هذه اهم نقطه ياالبناخي
--
امس لامس السعر وارتد الي 0.0026
--
مقاومة السهم قويه على 0.003 ويجب كسرها حتى نتأكد من صعود السهم.
--
--
امس لامس السعر وارتد الي 0.0026
--
مقاومة السهم قويه على 0.003 ويجب كسرها حتى نتأكد من صعود السهم.
--
لافي العتيبي
عضو نشط
- التسجيل
- 21 أغسطس 2006
- المشاركات
- 563
شفيها وقف التدوال عليها؟
al7bebe
عضو نشط
- التسجيل
- 24 مارس 2005
- المشاركات
- 10,052
حركه السهم بين محور 0.0024 و0.0029 وهذه اتجاهات السهم منذ ايام .
وسبق وان قلت لايتغير سلوك حركه السهم الا في خبر يصدر من الشركه.
.--
وسبق وان قلت لايتغير سلوك حركه السهم الا في خبر يصدر من الشركه.
دورة المؤشرنت للتحليل الفني
50 دينار كويتي